Modulation of the CD2 Receptor and Not Disruption of the CD2/CD48 Interaction Is the Principal Action of CD2-Mediated Immunosuppression in the Rat

This publication has 39 references indexed in Scilit:

• LONG-TERM SURVIVAL OF CARDIAC ALLOGRAFTS IN RATS TREATED BEFORE AND AFTER SURGERY WITH MONOCLONAL ANTIBODY TO CD2
  Transplantation, 1995
• The NH₂‐terminal domain of rat CD2 binds rat CD48 with a low affinity and binding does not require glycosylation of CD2
  European Journal of Immunology, 1993
• CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.
  The Journal of Experimental Medicine, 1992
• Overlapping but Nonidentical Binding Sites on CD2 for CD58 and a Second Ligand CD59
  Science, 1992
• Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1
  Science, 1992
• LFA-3, CD44, and CD45: Physiologic Triggers of Human Monocyte TNF and IL-1 Release
  Science, 1990
• The role of CD2/LFA-3 interaction in antigen- and mitogen-induced activation of human T cells
  International Immunology, 1989
• Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
  The Journal of Experimental Medicine, 1988
• Activation of rat T lymphocytes by anti-CD2 monoclonal antibodies.
  The Journal of Experimental Medicine, 1988
• Purified lymphocyte function‐associated antigen‐3 and T11 target structure are active in CD2‐mediated T cell stimulation
  European Journal of Immunology, 1987